Novo Nordisk, Emisphere in GLP-1 deal

Emisphere (NASDAQ:EMIS) gained $0.34 (17%) to $2.32 on Monday after granting Novo Nordisk (NYSE:NVO; CSE:NVO) an exclusive license to use eligen drug delivery technology to develop and commercialize o...